RNAC - Cartesian Therapeutics, Inc.
IEX Last Trade
19.7
-0.130 -0.660%
Share volume: 1,847
Last Updated: Thu 26 Dec 2024 08:14:53 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$19.83
-0.13
-0.66%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-08 | 2022-11-03 | 2023-03-02 | 2023-05-04 | 2023-08-17 | 2023-11-13 | 2024-03-07 | 2024-05-08 | |
| Total revenue | 39.273 M | 20.710 M | 16.795 M | 5.938 M | 5.249 M | 6.551 M | 8.266 M | 5.840 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 39.273 M | 20.710 M | 16.795 M | 5.938 M | 5.249 M | 6.551 M | 8.266 M | 5.840 M | |
| -47.27% | -18.90% | -64.64% | -11.60% | 24.80% | 26.18% | -29.35% | |||
| Operating expenses | 25.413 M | 22.309 M | 25.291 M | 24.319 M | 23.887 M | 19.616 M | 44.598 M | 19.188 M | |
| Selling general and admin | 6.231 M | 5.770 M | 6.324 M | 5.695 M | 6.105 M | 6.614 M | 22.167 M | 9.450 M | |
| Research and development | 19.182 M | 16.539 M | 18.967 M | 18.624 M | 17.782 M | 13.002 M | 22.431 M | 9.738 M | |
| Total expenses | 25.413 M | 22.309 M | 25.291 M | 24.319 M | 23.887 M | 19.616 M | 44.598 M | 19.188 M | |
| -12.21% | 13.37% | -3.84% | -1.78% | -17.88% | 127.36% | -56.98% | |||
| Operating income | 13.860 M | -1.599 M | -8.496 M | -18.381 M | -18.638 M | -13.065 M | -36.332 M | -13.348 M | |
| Ebit | 13.860 M | -1.599 M | -8.496 M | -18.381 M | -18.638 M | -13.065 M | -36.332 M | -13.348 M | |
| Pretax income | 8.601 M | -8.214 M | 5.605 M | -21.663 M | -11.387 M | -9.002 M | -196.658 M | -56.824 M | |
| -195.50% | -168.24% | -486.49% | -47.44% | -20.94% | 2,084.60% | -71.11% | |||
| Income tax | 0.000 | -321.000 K | -288.000 K | 0.000 | 0.000 | 0.000 | -19.000 M | 0.000 | |
| Net income basic | 8.601 M | -7.893 M | 5.893 M | -21.663 M | -11.387 M | -9.002 M | -177.658 M | -56.824 M | |
| -191.77% | 174.66% | -467.61% | 47.44% | 20.94% | -1,873.54% | 68.01% | |||
| Net income | 8.601 M | -7.893 M | 5.893 M | -21.663 M | -11.387 M | -9.002 M | -177.658 M | -56.824 M | |
| -191.77% | 174.66% | -467.61% | 47.44% | 20.94% | -1,873.54% | 68.01% |